More on IONS
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $54.65 |
|
|||
| Open | $54.10 | ||||
| 52 Wk High | $62.68 | ||||
| 52 Wk Low | $19.59 | ||||
| Day High | $54.69 | ||||
| Day Low | $53.76 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 2,572,047 | ||||
- Form 4 IONIS PHARMACEUTICALS For: Jul 15 Filed by: Reikes Peter N
- Form 4 IONIS PHARMACEUTICALS For: Jul 15 Filed by: HANTSON LUDWIG
- Form 4 IONIS PHARMACEUTICALS For: Jul 15 Filed by: HERMAN JOAN E
- Form 4 IONIS PHARMACEUTICALS For: Jul 15 Filed by: BERTHELSEN SPENCER R
- Wolfe Research Downgrades Ionis Pharmaceuticals (IONS) to Peerperform
- Form 4 IONIS PHARMACEUTICALS For: Jul 07 Filed by: BENNETT C FRANK
- Ionis to hold second quarter 2026 financial results webcast
- Increasing unusual option volume: BCE EQPT MDY DOMO CC IONS ARKG FRMM TOI DINO
- Biogen presents Phase 2 data on Alzheimer's drug diranersen at AAIC
- Ionis Partner Biogen Presents Phase 2 CELIA Data at AAIC Demonstrating Meaningful Clinical Outcomes and Robust Tau Reduction with Diranersen in Early Alzheimer’s Disease
Entities mentioned with IONS
- Twitter | View Related Stories »
- FDA | View Related Stories »
- Earnings | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- PDUFA | View Related Stories »
- Definitive Agreement | View Related Stories »
- Show More...
